欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2115/002
药品名称Sitagliptin/Metformin Grindeks
活性成分
    • metformin hydrochloride 1000.0 mg
    • Sitagliptin Hydrochloride monohydrate 50.0 mg
剂型Film-coated tablet
上市许可持有人Grindeks AS, Latvia
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Ireland (IE)
    • Estonia (EE)
    • Austria (AT)
    • Hungary (HU)
    • France (FR)
    • Bulgaria (BG)
      Sitagliptin/Metformin Grindeks
    • Spain (ES)
    • Czechia (CZ)
      SItagliptin/Metfromin Grindeks
    • Portugal (PT)
    • Romania (RO)
      Sitagliptin/Metformin Grindeks 50/1000 mg comprimate filmate
    • Italy (IT)
    • Slovakia (SK)
    • Greece (GR)
    • Slovenia (SI)
    • Germany (DE)
      Sitagliptin/Metformin Grindeks 50/1000 mg Filmtabletten
    • Norway (NO)
    • Croatia (HR)
    • Denmark (DK)
      Sitagliptin/Metformin Grindeks
    • Finland (FI)
    • Belgium (BE)
    • Poland (PL)
      Sitagliptin + Metformin Grindeks
    • Netherlands (NL)
    • Latvia (LV)
    • Luxembourg (LU)
    • Lithuania (LT)
      -
许可日期2022/01/24
最近更新日期2024/08/22
药物ATC编码
    • A10BD07 metformin and sitagliptin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase